Morgan Stanley Has $207.50 Million Position in U.S. Bancorp (USB)

Share on StockTwits

Morgan Stanley boosted its position in shares of U.S. Bancorp (NYSE:USB) by 6.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,148,385 shares of the financial services provider’s stock after purchasing an additional 243,361 shares during the period. Morgan Stanley’s holdings in U.S. Bancorp were worth $207,503,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in USB. Clearwater Capital Advisors LLC bought a new position in U.S. Bancorp during the 1st quarter valued at about $100,000. Horan Capital Management bought a new position in U.S. Bancorp during the 2nd quarter valued at about $109,000. Well Done LLC bought a new position in U.S. Bancorp during the 1st quarter valued at about $117,000. Integrated Investment Consultants LLC bought a new position in U.S. Bancorp during the 2nd quarter valued at about $135,000. Finally, Mount Yale Investment Advisors LLC bought a new position in U.S. Bancorp during the 1st quarter valued at about $141,000. 74.35% of the stock is owned by hedge funds and other institutional investors.

In other news, Vice Chairman John R. Elmore sold 58,924 shares of U.S. Bancorp stock in a transaction that occurred on Monday, July 23rd. The shares were sold at an average price of $51.71, for a total transaction of $3,046,960.04. Following the completion of the sale, the insider now owns 98,371 shares in the company, valued at approximately $5,086,764.41. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.43% of the stock is owned by insiders.

Shares of NYSE USB opened at $54.14 on Friday. U.S. Bancorp has a 1-year low of $48.49 and a 1-year high of $58.50. The stock has a market capitalization of $87.24 billion, a price-to-earnings ratio of 14.36, a P/E/G ratio of 1.76 and a beta of 0.98. The company has a quick ratio of 0.82, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

U.S. Bancorp (NYSE:USB) last announced its earnings results on Wednesday, July 18th. The financial services provider reported $1.02 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.01. U.S. Bancorp had a net margin of 26.96% and a return on equity of 14.66%. The company had revenue of $5.64 billion during the quarter, compared to the consensus estimate of $5.64 billion. During the same period in the previous year, the firm posted $0.25 earnings per share. The company’s revenue was up 3.5% on a year-over-year basis. equities research analysts anticipate that U.S. Bancorp will post 4.07 earnings per share for the current year.

Several brokerages recently issued reports on USB. ValuEngine downgraded shares of U.S. Bancorp from a “hold” rating to a “sell” rating in a report on Monday, July 2nd. Wedbush reaffirmed a “neutral” rating on shares of U.S. Bancorp in a research note on Monday, July 23rd. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have given a buy rating to the stock. U.S. Bancorp has a consensus rating of “Hold” and an average price target of $58.58.

U.S. Bancorp Profile

U.S. Bancorp, a financial services holding company, provides various financial services in the United States. The company operates through five segments: Corporate and Commercial Banking, Consumer and Business Banking, Wealth Management and Investment Services, Payment Services, and Treasury and Corporate Support.

Featured Article: Average Daily Trade Volume – ADTV

Want to see what other hedge funds are holding USB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Bancorp (NYSE:USB).

Institutional Ownership by Quarter for U.S. Bancorp (NYSE:USB)

Receive News & Ratings for U.S. Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.